IP Library Granted Patent US 11,324,898
Granted Patent B2
US 11,324,898 · App. 16/781,051 · Granted May 10, 2022

System and method for infusion set dislodgement detection

Inventor: Michael Rosinko (Anaheim, CA)
Assignee: Tandem Diabetes Care, Inc.
A61M5/5086A61M5/16836A61M2205/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,324,898
App. No.
16/781,051
Granted
May 10, 2022
Kind
B2
Abstract

A portable insulin pump can utilize readings from a sensor incorporated into an infusion set used with the pump to deliver insulin to a patient to determine if the infusion set is or is likely to become dislodged from the patient. Readings from the sensor that are inconsistent with expected readings or a range of expected readings can indicate that the infusion set has become dislodged from the patient.

Claims (40)

1. A method of providing diabetes therapy to a patient with a portable infusion pump, comprising:

delivering medicament to a patient with the portable infusion pump through an infusion set including infusion tubing extending from the portable infusion pump and a cannula inserted into the patient to deliver the medicament to the patient through the cannula;

monitoring glucose levels of the patent with data obtained by a glucose sensor while the medicament is delivered to the patient;

determining that the monitored glucose levels are inconsistent with expected readings;

determining, due to the monitored glucose levels being inconsistent with expected readings, that the patient may not be receiving the medicament through the cannula; and

providing a visual alert to the patient on a display to check the infusion set in response to the determination that the patient may not be receiving the medicament through the cannula.

2. The method of claim 1 , wherein determining that the monitored glucose levels are inconsistent with expected readings includes determining that the glucose levels are higher than expected.

3. The method of claim 1 , wherein providing a visual alert to the patient on a display to check the infusion set includes providing a textual alert instructing the user to check the infusion set.

4. The method of claim 1 , wherein providing a visual alert to the patient on a display to check the infusion set includes providing the alert on a display of the portable infusion pump.

5. The method of claim 1 , wherein providing a visual alert to the patient on a display to check the infusion set includes providing the alert on a display of a remote control device for the portable infusion pump.

6. The method of claim 1 , further comprising providing on the display a selectable icon for the patient to respond to the alert.

7. The method of claim 1 , further comprising discontinuing delivery of medicament with the portable infusion pump upon determining that the patient may not be receiving the medicament through the cannula.

8. A method of providing diabetes therapy to a patient with a portable infusion pump, comprising:

delivering medicament to a patient with the portable infusion pump through an infusion set including infusion tubing extending from the portable infusion pump and a cannula inserted into the patient to deliver the medicament to the patient through the cannula;

monitoring glucose levels of the patent with data obtained by a glucose sensor while the medicament is delivered to the patient;

determining that the monitored glucose levels are not responding to delivery of the medicament as expected; and

providing a visual alert to the patient on a display to check the infusion set in response to the determination that the monitored glucose levels are not responding to delivery of the medicament as expected.

9. The method of claim 8 , wherein determining that the monitored glucose levels are not responding to delivery of the medicament as expected includes determining that the glucose levels are higher than expected.

10. The method of claim 8 , wherein providing a visual alert to the patient on a display to check the infusion set includes providing a textual alert instructing the user to check the infusion set.

11. The method of claim 8 , wherein providing a visual alert to the patient on a display to check the infusion set includes providing the alert on a display of the portable infusion pump.

12. The method of claim 8 , wherein providing a visual alert to the patient on a display to check the infusion set includes providing the alert on a display of a remote control device for the portable infusion pump.

13. The method of claim 8 , further comprising discontinuing delivery of medicament with the portable infusion pump upon determining that the monitored glucose levels are not responding to delivery of the medicament as expected.

14. A portable infusion pump system, comprising:

a reservoir configured to contain a medicament;

a delivery mechanism configured to deliver the medicament to a patient through an infusion set including infusion tubing extending to the patient and a cannula inserted into the patient to deliver the medicament to the patient through the cannula;

a user interface adapted to display operating information and to receive input data from the patient;

a receiver adapted to receive data relating to glucose levels of the patient obtained by a glucose sensor; and

a processor configured to:

cause the delivery mechanism to deliver the medicament to the patient through the infusion set;

monitor glucose levels of the patent with the data obtained by the glucose sensor while the medicament is delivered to the patient;

determine that the monitored glucose levels are inconsistent with expected readings;

determine, due to the monitored glucose levels being inconsistent with expected readings, that the patient may not be receiving the medicament through the cannula; and

provide a visual alert to the patient on the user interface to check the infusion set in response to the determination that the patient may not be receiving the medicament through the cannula.

15. The system of claim 14 , wherein the processor is configured to determine that the monitored glucose levels are inconsistent with expected readings by determining that the glucose levels are higher than expected.

16. The system of claim 14 , wherein the processor is configured to provide the visual alert to the patient on the user interface by providing a textual alert instructing the user to check the infusion set.

17. The system of claim 14 , wherein the user interface is part of a portable infusion pump that includes the delivery mechanism.

18. The system of claim 14 , wherein the user interface is part of a remote control device for remotely controlling a portable infusion pump that includes the delivery mechanism.

19. The system of claim 14 , wherein the processor is further configured to display a selectable icon for the patient to respond to the alert on the user interface.

20. The system of claim 14 , wherein the processor is further configured to discontinue delivery of the medicament upon determining that the patient may not be receiving the medicament through the cannula.

21. The method of claim 8 , further comprising providing on the display a selectable icon for the patient to respond to the alert.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2020
From: ROSINKO, MICHAEL
To: TANDEM DIABETES CARE, INC.
Reel/Frame 051708/0613 →
Continuity (3)
Continuation 15871665 · Jan 15, 2018
Continuation 13923556 · Jun 21, 2013
Related Publication 20200171249A1 · Jun 4, 2020
Cited By (1)
US 12,431,104